Department of Pathology, Castle Hill Hospital, Cottingham, Hull, UK.
Ann Surg Oncol. 2009 Dec;16(12):3267-70. doi: 10.1245/s10434-009-0727-7. Epub 2009 Oct 10.
The diagnosis of invasive malignancy on biopsies from colorectal neoplasms can be challenging. The concept of intramucosal carcinoma as an indicator of invasive malignancy is somewhat controversial within histopathology circles despite current World Health Organization (WHO) definitions. This study was designed to correlate the biopsy finding of intramucosal carcinoma with the pathology findings after formal surgical excision.
We evaluated 89 patients whose initial forceps biopsy contained only intramucosal carcinoma. All tumors were subsequently resected and subjected to formal pathology assessment.
Of 89 patients, 97% were shown to have frankly invasive adenocarcinoma by the current WHO definition. The positive predictive value of intramucosal carcinoma at biopsy for invasive cancer was 96.6%
This study indicated that there should be a greater willingness among colorectal pathologists to accept the biopsy finding of intramucosal carcinoma as the earlier form of invasive malignancy. Clinicians should alter their treatment algorithms accordingly.
从结直肠肿瘤活检中诊断浸润性恶性肿瘤具有一定挑战性。尽管目前的世界卫生组织(WHO)定义,黏膜内癌作为浸润性恶性肿瘤的指标在组织病理学领域仍存在一定争议。本研究旨在将黏膜内癌的活检发现与正式手术切除后的病理发现进行相关性分析。
我们评估了 89 例初始活检仅包含黏膜内癌的患者。所有肿瘤随后均被切除并进行正式的病理评估。
89 例患者中,97%按照当前 WHO 定义被明确诊断为浸润性腺癌。活检中黏膜内癌诊断为浸润性癌的阳性预测值为 96.6%。
本研究表明,结直肠病理学家应该更愿意接受活检中黏膜内癌作为浸润性恶性肿瘤的早期表现。临床医生应相应调整其治疗方案。